This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US

ONLINE REGISTRATION CLOSES IN:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
December 15 - 18, 2024
Marriott Marquis San DiegoLive In-Person Event: December 15 - 18, 2024

Allison Schulkins
Chief Operating Officer at Single Cell Technology
Speaker

Profile

Allison Schulkins is the COO at Single Cell Technology. She has been leading improvements in cell isolation, antibody screening, and sequence amplification techniques to transform the AbTheneum platform into a powerful pipeline. She harmonizes the engineering and biology aspects of the platform and works with clients to apply AbTheneum technology to their drug discovery challenges. She has a B.S. in Biochemistry from University of California, Santa Barbara and an M.S. in Chemical Engineering from San Jose State University.

Allison Schulkins's Network

Agenda Sessions

  • Breaking Barriers in Antibody Discovery with Innovative Cell Isolation

    1:45pm